Updated daily
View our work on COVID-19 vaccinations

Coronavirus (COVID-19) Vaccinations

Our international COVID-19 vaccination dataset is updated each morning (London time), with data up to the previous day.
Reuse our work freelyCite this research

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

In our Data Explorer you can see all of our data on COVID-19 vaccinations (doses administered, people with at least 1 dose, and people fully vaccinated).

Open the Data Explorer in a new tab.

Select a group of countries at once: all European countries, 30 largest countries; EU; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

What share of the population has been partly or fully vaccinated against COVID-19?

The following charts show the breakdown of vaccinations by those that have been partly or fully vaccinated. A person is considered partly vaccinated if they have received only one dose of a 2-dose vaccine protocol. A person is considered fully vaccinated if they have received a single-dose vaccine or both doses of a two-dose vaccine.

How many COVID-19 vaccine doses are administered daily?

Daily number of COVID-19 vaccinations administered per 100 people

The following chart shows the daily number of COVID-19 vaccination doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered

How many COVID-19 vaccination doses have been administered?

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime, as several available COVID vaccines require multiple doses.

Total number of COVID-19 vaccinations administered

The following chart shows the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

What share of the population has received at least one dose of the COVID-19 vaccine?

The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine. This may not equal the share that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of the COVID-19 vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has been fully vaccinated against COVID-19?

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Total number of people who have been fully vaccinated against COVID-19

The following chart shows the total number of people that have been fully vaccinated against COVID-19. This represents the number that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

How many vaccine booster doses have been administered?

The following charts show the number of booster doses administered. Booster doses are doses administered beyond those prescribed by the original vaccination protocol — for example, a third dose of Pfizer/BioNTech vaccine, or a second dose of Johnson & Johnson vaccine.

Vaccinations by age

The following charts provide data on the share of people that have been vaccinated against COVID-19 by age group. This is provided as three metrics: the share that have received at least one dose; the share that have been fully vaccinated; and the share that are only partly vaccinated.

Some of this data is only available for countries which report the breakdown of doses administered by first and second doses by age.

Share that have received at least one dose by age

The following chart shows the share of the population in each age group that have received at least one dose of the COVID-19 vaccine. This metric includes those that are either partly or fully vaccinated.

Fully vaccinated by age

The following chart shows the share of the population in each age group that are fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol.

Share that have received a booster dose by age

The following chart shows the share of the population in each age group that has received a booster dose against COVID-19.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer. This is only available for a select number of countries which report the necessary data.

How many doses have been donated by each country?

These charts show the cumulative number of doses donated to the COVAX initiative by different countries, broken down by whether the donations have only been announced, actually donated, or delivered to the recipients. This is only available for a select number of countries for which the COVID-19 Task Force reports the necessary data.

The three following charts show the number of doses donated, adjusted for:

  1. The population of the donating country;
  2. The GDP of the donating country;
  3. The number of doses administered by the donating country to its own population.

COVID-19 Vaccines Global Access (COVAX)

COVAX is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccinations

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 218 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationJan. 24, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
AlbaniaMinistry of HealthJan. 13, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaWorld Health OrganizationJan. 9, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
AndorraWorld Health OrganizationJan. 16, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationJan. 23, 2022Oxford/AstraZeneca
AnguillaWorld Health OrganizationJan. 21, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Antigua and BarbudaMinistry of HealthJan. 13, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
ArgentinaMinistry of HealthJan. 23, 2022CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
ArmeniaWorld Health OrganizationJan. 23, 2022Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
ArubaGovernment of ArubaJan. 23, 2022Pfizer/BioNTech
AustraliaGovernment of Australia via CovidBaseAUJan. 24, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BahamasPan American Health OrganizationJan. 12, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
BahrainMinistry of HealthJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesJan. 24, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BarbadosMinistry of HealthJan. 22, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BelarusWorld Health OrganizationJan. 16, 2022Sinopharm/Beijing, Sputnik V
BelgiumSciensanoJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeWorld Health OrganizationJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BeninMinistry of HealthJan. 18, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BermudaPan American Health OrganizationJan. 19, 2022Oxford/AstraZeneca, Pfizer/BioNTech
BhutanWorld Health OrganizationJan. 16, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BoliviaMinistry of Health via https://www.boligrafica.com/Jan. 20, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationSep. 1, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaWorld Health OrganizationNov. 30, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaAfrica Centres for Disease Control and PreventionJan. 17, 2022Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BrazilState governments via coronavirusbra1.github.ioJan. 24, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
British Virgin IslandsWorld Health OrganizationJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca
BruneiWorld Health OrganizationJan. 14, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BulgariaMinistry of HealthJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Burkina FasoWorld Health OrganizationJan. 13, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
BurundiWorld Health OrganizationJan. 13, 2022Sinopharm/Beijing
CambodiaMinistry of HealthJan. 23, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CameroonWorld Health OrganizationJan. 9, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caJan. 24, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationJan. 14, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Cayman IslandsWorld Health OrganizationJan. 21, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicAfrica Centres for Disease Control and PreventionJan. 21, 2022Covaxin, Oxford/AstraZeneca
ChadAfrica Centres for Disease Control and PreventionJan. 16, 2022Sinopharm/Beijing
ChileMinisterio de Ciencia, Tecnología, Conocimiento e InnovaciónJan. 21, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionJan. 24, 2022CanSino, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001
ColombiaMinistry of HealthJan. 21, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationDec. 31, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoAfrica Centres for Disease Control and PreventionDec. 28, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Cook IslandsSPC Public Health DivisionJan. 18, 2022Pfizer/BioNTech
Costa RicaCosta Rican Social Security FundJan. 17, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Cote d’IvoireWorld Health OrganizationJan. 18, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
CroatiaMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthJan. 22, 2022Abdala, Soberana02
CuracaoGovernment of CuracaoJan. 23, 2022Moderna, Pfizer/BioNTech
CyprusMinistry of HealthJan. 22, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Democratic Republic of CongoWorld Health OrganizationJan. 20, 2022Oxford/AstraZeneca
DenmarkStatens Serum InstituteJan. 23, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
DjiboutiWorld Health OrganizationJan. 17, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
DominicaPan American Health OrganizationJan. 21, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Dominican RepublicMinistry of Public HealthJan. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidJan. 22, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
El SalvadorMinistry of HealthJan. 20, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EnglandGovernment of the United KingdomJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthJan. 18, 2022Sinopharm/Beijing
EstoniaNational Health BoardJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniWorld Health OrganizationJan. 23, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
EthiopiaMinistry of HealthJan. 24, 2022Oxford/AstraZeneca
Faeroe IslandsGovernment of the Faeroe IslandsJan. 20, 2022Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionJan. 18, 2022Oxford/AstraZeneca
FinlandFinnish Institute for Health and WelfareJan. 20, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
French PolynesiaSPC Public Health DivisionJan. 18, 2022Johnson&Johnson, Pfizer/BioNTech
GabonAfrica Centres for Disease Control and PreventionJan. 16, 2022Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
GambiaAfrica Centres for Disease Control and PreventionJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
GeorgiaNational Center for Disease Control and Public HealthJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
GermanyRobert Koch InstitutJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaWorld Health OrganizationJan. 17, 2022Oxford/AstraZeneca, Sputnik V
GibraltarGovernment of GibraltarJan. 22, 2022Pfizer/BioNTech
GreeceMinistry of HealthJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandJan. 24, 2022Moderna
GrenadaWorld Health OrganizationJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
GuatemalaMinistry of HealthJan. 23, 2022Moderna, Oxford/AstraZeneca
GuernseyGovernment of GuernseyJan. 17, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyJan. 15, 2022Sputnik V
Guinea-BissauWorld Health OrganizationJan. 22, 2022Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthJan. 21, 2022Oxford/AstraZeneca, Sputnik V
HaitiPan American Health OrganizationJan. 1, 2022Johnson&Johnson, Moderna
HondurasWorld Health OrganizationJan. 21, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
Hong KongGovernment of Hong KongJan. 24, 2022Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthJan. 20, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaJan. 24, 2022Covaxin, Oxford/AstraZeneca, Sputnik V
IndonesiaGovernment of IndonesiaJan. 24, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
IranWorld Health OrganizationJan. 24, 2022COVIran Barekat, Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Soberana02, Sputnik V
IraqWorld Health OrganizationJan. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IrelandHeath Service ExecutiveJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelJan. 24, 2022Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JapanPrime Minister’s OfficeJan. 24, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JerseyGovernment of JerseyJan. 19, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JordanGovernment of JordanJan. 19, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
KazakhstanGovernment of KazakhstanJan. 24, 2022QazVac, Sinopharm/Beijing, Sputnik V
KenyaMinistry of HealthJan. 24, 2022Oxford/AstraZeneca, Sputnik V
KiribatiSPC Public Health DivisionJan. 11, 2022Oxford/AstraZeneca
KosovoMinistry of HealthJan. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech
KuwaitWorld Health OrganizationJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
KyrgyzstanMinistry of HealthJan. 24, 2022Sinopharm/Beijing, Sputnik V
LaosWorld Health OrganizationJan. 18, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LatviaNational Health ServiceJan. 24, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
LebanonGovernment of LebanonJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
LesothoWorld Health OrganizationDec. 31, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
LiberiaWorld Health OrganizationDec. 31, 2021Oxford/AstraZeneca
LibyaWorld Health OrganizationJan. 22, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
LiechtensteinFederal Office of Public HealthJan. 23, 2022Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgJan. 22, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoJan. 24, 2022Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationJan. 5, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MalawiMinistry of HealthJan. 23, 2022Johnson&Johnson, Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaJan. 24, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
MaldivesPresidency of the MaldivesJan. 19, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
MaliWorld Health OrganizationJan. 21, 2022Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaAfrica Centres for Disease Control and PreventionJan. 16, 2022Oxford/AstraZeneca, Sinopharm/Beijing
MauritiusWorld Health OrganizationDec. 28, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoSecretary of HealthJan. 24, 2022CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthJan. 24, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MonacoNational CouncilSep. 16, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratWorld Health OrganizationJan. 21, 2022Oxford/AstraZeneca
MoroccoWorld Health OrganizationJan. 22, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MozambiqueWorld Health OrganizationJan. 19, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarWorld Health OrganizationJan. 16, 2022Oxford/AstraZeneca, Sinopharm/Beijing
NamibiaAfrica Centres for Disease Control and PreventionJan. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
NauruWorld Health OrganizationJan. 18, 2022Oxford/AstraZeneca
NepalWorld Health OrganizationJan. 16, 2022Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
NetherlandsEuropean CDC, via Marino van ZelstJan. 22, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionJan. 18, 2022Pfizer/BioNTech
New ZealandMinistry of HealthJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech
NicaraguaWorld Health OrganizationJan. 19, 2022Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V
NigerWorld Health OrganizationJan. 10, 2022Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaWorld Health OrganizationJan. 22, 2022Oxford/AstraZeneca
NiueSPC Public Health DivisionAug. 2, 2021Oxford/AstraZeneca
North MacedoniaGovernment of North MacedoniaJan. 16, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Northern CyprusMinistry of HealthNov. 26, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthJan. 23, 2022Moderna, Pfizer/BioNTech
OmanWorld Health OrganizationJan. 17, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PakistanNational Command and Operation CentreJan. 24, 2022CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Palestine (see FAQ)World Health OrganizationJan. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PanamaPan American Health OrganizationJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaSPC Public Health DivisionJan. 18, 2022Oxford/AstraZeneca
ParaguayPan American Health OrganizationJan. 21, 2022Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
PeruMinisterio de Salud via github.com/jmcastagnetto/covid-19-peru-vacunasJan. 22, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesDepartment of Health via ABS-CBN Investigative and Research GroupJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PitcairnSPC Public Health DivisionSep. 7, 2021Oxford/AstraZeneca
PolandMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthJan. 24, 2022Moderna, Pfizer/BioNTech
RomaniaGovernment of Romania via datelazi.roJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruJan. 24, 2022EpiVacCorona, Sputnik V
RwandaWorld Health OrganizationJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Saint HelenaGovernment of Saint HelenaMay. 5, 2021Oxford/AstraZeneca
Saint Kitts and NevisPan American Health OrganizationJan. 21, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Saint LuciaMinistry of HealthJan. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Saint Vincent and the GrenadinesMinistry of HealthDec. 28, 2021Oxford/AstraZeneca
SamoaSPC Public Health DivisionJan. 18, 2022Oxford/AstraZeneca
San MarinoWorld Health OrganizationJan. 16, 2022Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeWorld Health OrganizationJan. 17, 2022Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalWorld Health OrganizationJan. 6, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
SerbiaGovernment of SerbiaJan. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesWorld Health OrganizationJan. 18, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Sierra LeoneWorld Health OrganizationJan. 11, 2022Oxford/AstraZeneca, Sinopharm/Beijing
SingaporeGovernment of SingaporeJan. 17, 2022Moderna, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
Sint Maarten (Dutch part)World Health OrganizationJan. 21, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
SloveniaNational Institute of Public Health via covid-19.sledilnik.orgJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionJan. 18, 2022Oxford/AstraZeneca
SomaliaWorld Health OrganizationJan. 16, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
South AfricaMinistry of HealthJan. 24, 2022Johnson&Johnson, Pfizer/BioNTech
South KoreaKorea Centers for Disease Control and PreventionJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
South SudanWorld Health OrganizationJan. 23, 2022Johnson&Johnson, Oxford/AstraZeneca
SpainMinistry of HealthJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitJan. 24, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SudanWorld Health OrganizationJan. 23, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
SurinameGovernment of SurinameJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
SwedenPublic Health Agency of SwedenJan. 21, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthJan. 23, 2022Moderna, Pfizer/BioNTech
SyriaWorld Health OrganizationJan. 15, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
TaiwanTaiwan Centers for Disease ControlJan. 24, 2022Medigen, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
TajikistanWorld Health OrganizationJan. 16, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
TanzaniaWorld Health OrganizationDec. 28, 2021Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing
ThailandGovernment of ThailandJan. 20, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
TimorWorld Health OrganizationJan. 18, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
TogoWorld Health OrganizationJan. 21, 2022Oxford/AstraZeneca
TokelauSPC Public Health DivisionOct. 12, 2021Pfizer/BioNTech
TongaSPC Public Health DivisionJan. 18, 2022Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthJan. 24, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
TunisiaMinistry of HealthJan. 22, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformJan. 24, 2022Pfizer/BioNTech, Sinovac, Turkovac
TurkmenistanWorld Health OrganizationAug. 29, 2021EpiVacCorona, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Turks and Caicos IslandsWorld Health OrganizationNov. 5, 2021Pfizer/BioNTech
TuvaluWorld Health OrganizationOct. 22, 2021Oxford/AstraZeneca
UgandaWorld Health OrganizationJan. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UkraineMinistry of HealthJan. 24, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionJan. 24, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of Health via vacuna.uyJan. 24, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanGovernment of UzbekistanJan. 23, 2022Moderna, Oxford/AstraZeneca, Sputnik V, ZF2001
VanuatuSPC Public Health DivisionDec. 20, 2021Oxford/AstraZeneca
VenezuelaPan American Health OrganizationDec. 17, 2021Abdala, Sinopharm/Beijing, Sinovac, Sputnik V
VietnamWorld Health OrganizationJan. 23, 2022Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
WalesGovernment of the United KingdomJan. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionJan. 18, 2022Moderna
YemenWorld Health OrganizationJan. 20, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinovac
ZambiaGovernment of ZambiaJan. 24, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
ZimbabweMinistry of HealthJan. 23, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V

Frequently-asked questions

Why do the figures displayed on this page look different from the ones published by my government?

In some cases, the vaccination figures on this page can look different from the ones reported by a government. Most often it is not because of the numerator (number of people vaccinated) but instead because of the denominator (number of people in the population). This usually happens for two main reasons:

  1. The official data reports the vaccination coverage in terms of the share of people vaccinated in the population eligible for vaccination (very often, among adults only). Our priority is to make our data comparable between countries — regardless of criteria for eligibility, which tend to vary across countries and across time. For this reason, we always use the total population of the country (i.e. people of all ages) as the denominator.
  2. The official data uses a different population estimate. The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier (see below for more information). In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.
What population data are the per-capita metrics based on?

The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier. The exact values can be viewed in our GitHub repository.

The United Nations estimates may not always reflect the latest censuses or national figures—but there are several reasons why we use this data over country-by-country national population estimates.

  • The UNWPP dataset is the standard in research. The main reason is that it uses a reliable and standardized methodology for all countries. For example, if we used individual country data, some may include overseas workers, expats, undocumented immigrants, etc. but others wouldn’t.
  • Using data from the UN allows us to get accurate population estimates for all territories in the world very easily. Finding and maintaining estimates based on national censuses would be very time-consuming for our small team, without bringing much additional value to our work.
  • Other reasons include the availability of yearly data (national censuses are only conducted every few years), and avoiding double-counting in cases of border disputes.

For all these reasons, the UN data is the best solution to bring accurate per-capita metrics to our COVID data. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

What is the definition of a fully-vaccinated person?

In our data, fully-vaccinated people are those who have received all doses prescribed by their vaccination regimen (e.g. 2 doses for Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, etc. and 1 dose for Johnson & Johnson, CanSino, etc.).

Some countries also allow for alternative definitions, such as having been infected with SARS-CoV-2 in the past and having received 1 dose of a two-dose regimen. We currently ignore these alternative definitions to preserve the common definition of fully vaccinated, i.e. all doses required in the vaccine regimen. This allows for an optimal comparability between countries.

What classification are the income groups based on?

The income groups we use come from the World Bank income classification. The exact list of countries can be viewed in our GitHub repository.

Why isn’t my country shown by default on a chart? How do you choose which countries are shown?

Due to the limited space on our charts and the number of countries in the world, we unfortunately cannot show every country in the world by default. On each chart of this page, we therefore choose a default selection of countries based on a mix of criteria: mainly total population, but also number of vaccine doses administered and share of the population vaccinated. These lists are updated about once a month.

In the future, we plan to develop new features that would allow the list of countries to automatically adapt to the region of each visitor, and if they allow it, to use cookies to save their default list on their computer.

How can we best estimate how many people have been vaccinated globally?

Because some countries — notably China, as of August 2021 — do not report breakdowns between first and second doses administered, we cannot know the exact number of people with at least 1 dose and people fully vaccinated in the world. The figures displayed on our charts for “World” only include data from countries that do publish this more precise information. Therefore, as long as some countries are only reporting partial data, these figures will underestimate the real number of people vaccinated and fully vaccinated globally.

Based on the number of doses administered, it is however possible to calculate a lower and upper bound of how many people have been vaccinated in these countries. For example, if 500 million doses have been used in China, they must have been administered to at least 250 million people (with 2 doses each), and up to 500 million people (with only 1 dose each).

We recommend citing the figure on our charts as the “confirmed number of people with at least 1 dose”.

A good proxy for estimating the “complete number of people with at least 1 dose” is:

My country has started vaccinating its population. Why is it missing from the charts?

Other countries that are not shown in our data may have also started vaccination campaigns. We’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources. If you’re aware of an official source reporting numbers, please let us know using the “Feedback” button at the bottom of your screen.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.


Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.